PL402105A1 - Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging - Google Patents

Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging

Info

Publication number
PL402105A1
PL402105A1 PL402105A PL40210512A PL402105A1 PL 402105 A1 PL402105 A1 PL 402105A1 PL 402105 A PL402105 A PL 402105A PL 40210512 A PL40210512 A PL 40210512A PL 402105 A1 PL402105 A1 PL 402105A1
Authority
PL
Poland
Prior art keywords
composition
thioproline
rosmarinic acid
skin
aging
Prior art date
Application number
PL402105A
Other languages
Polish (pl)
Other versions
PL220399B1 (en
Inventor
Irena Szołomicka-Orfinger
Katarzyna Rogiewicz
Renata Dębowska
Monika Pasikowska
Original Assignee
Laboratorium Kosmetyczne Dr Irena Eris Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorium Kosmetyczne Dr Irena Eris Spółka Z Ograniczoną Odpowiedzialnością filed Critical Laboratorium Kosmetyczne Dr Irena Eris Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL402105A priority Critical patent/PL220399B1/en
Publication of PL402105A1 publication Critical patent/PL402105A1/en
Publication of PL220399B1 publication Critical patent/PL220399B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Wynalazek dotyczy kompozycji oraz preparatu zawierającego tioprolinę i kwas rozmarynowy w synergicznie skutecznej ilości. Wynalazek dotyczy ponadto zastosowania kompozycji zawierającej tioprolinę i kwas rozmarynowy do spowalniania, przeciwdziałania, zapobiegania procesowi starzenia zewnątrzpochodnego oraz sposobu spowalniania, przeciwdziałania, zapobiegania procesowi starzenia zewnątrzpochodnego skóry.The invention relates to a composition and preparation containing thioproline and rosmarinic acid in a synergistically effective amount. The invention further relates to the use of a composition comprising thioproline and rosmarinic acid for slowing, counteracting, preventing extrinsic aging and a method of slowing, preventing, preventing skin extrinsic aging.

PL402105A 2012-12-17 2012-12-17 Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging PL220399B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL402105A PL220399B1 (en) 2012-12-17 2012-12-17 Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL402105A PL220399B1 (en) 2012-12-17 2012-12-17 Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging

Publications (2)

Publication Number Publication Date
PL402105A1 true PL402105A1 (en) 2014-06-23
PL220399B1 PL220399B1 (en) 2015-10-30

Family

ID=50943742

Family Applications (1)

Application Number Title Priority Date Filing Date
PL402105A PL220399B1 (en) 2012-12-17 2012-12-17 Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging

Country Status (1)

Country Link
PL (1) PL220399B1 (en)

Also Published As

Publication number Publication date
PL220399B1 (en) 2015-10-30

Similar Documents

Publication Publication Date Title
BR112016003201A2 (en) selective grp94 inhibitors and uses thereof
BR112016014410A2 (en) neoantigen vaccine combination therapy
PH12014502757B1 (en) Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
EA201301240A1 (en) POLYMORPHIC FORMULA BENZOA LIGNOGLIPTINA
NZ702087A (en) Pharmaceutical compositions and treatment of mastitis
MY168959A (en) Vaccine compositions for the prevention of dengue virus infection
PH12014502875A1 (en) Vaccine compositions for prevention against dengue virus infection
DOP2016000253A (en) NEW COMPOUNDS
PH12015501982A1 (en) Pharmaceutical compositions comprising everolimus
MX2015010310A (en) Compositions comprising gougerotin and an insecticide.
EA201590491A1 (en) IMMUNOGENIC COMPOSITION
NZ708821A (en) Lfa-1 inhibitor formulations
NZ702930A (en) Racecadotril liquid compositions
EP2931310A4 (en) Compositions, methods of administration and uses for trivalent dengue virus formulations
MX2015000485A (en) Treatment of multiple sclerosis with combination of laquinimod and fampridine.
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
KR101501876B9 (en) Composition for preventing or treating influenza virus infection containing xylitol as an active ingredient
BR112015002984A2 (en) composition, vaccine to protect an animal against infection with leptospira bacteria, and use of citric acid.
PL402105A1 (en) Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging
PL397785A1 (en) Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process
MX2016003763A (en) Laquinimod combination therapy for treatment of multiple sclerosis.
MX368416B (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
PL404567A1 (en) Preparation containing diosgenin and sucralfate, the use of this preparation and a method of protecting the skin against endogenous aging
PL407256A1 (en) Application of the composition and preparation containing thioproline and rosemary acid, method for deceleration, counteracting and preventing the process of formation of skin vitiligo spots
UA106123C2 (en) 1-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-(1-aryl-1h- tetrazol-5-ylsulfonyl)ethanone derivatives exhibiting antioxidant properties